>>14904098 pb
>>14904370 pb
CDC Pediatric COVID-19 Vaccination Operational Planning Guide for children
note: pre-ordered purchases of vaccines before authorization.
ASSUMPTIONS
• FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is
scheduled to meet on October 26th. The CDC’s Advisory Committee on Immunization
Practices (ACIP) is scheduled to meet on November 2nd and 3rd, 2021. Jurisdictions
should be ready to vaccinate children 5–11 years old shortly thereafter, pending FDA
authorization and CDC recommendations.
• To ensure efficient rollout of vaccine supply, jurisdictions should plan their ordering
strategy now and identify the priority locations and sequence of activating these priority
locations during the initial weeks of the pediatric vaccination efforts.
• Shipment for pediatric vaccines can begin once FDA issues the EUA, and vaccine
administration can begin once the CDC Director makes a recommendation.
o For the initial roll out, a large, one-time bolus of pediatric product will be made
available pro-rata for jurisdictions to pre-order.
▪ Pre-orders will occur in three waves beginning October 20th. Jurisdictions
will have 48 hours to enter orders for each wave.
▪ Wave 1: Order cap will be raised October 20th
▪ Wave 2: Order cap will be raised again on October 22nd
▪ Wave 3: Order cap will be raised again on October 24th. This will be the
final order cap raise of the initial launch period, and standard order cap
cycles will begin the first full week of the launch.
▪ Pre-ordering through these waves will allow for a manageable and
equitable launch for this new vaccine
o This bolus of supply will ensure that vaccine can be placed in many locations
nationwide, making it easier for children to get vaccinated. These doses will
remain in ordering caps for jurisdictions to order as needed. Second dose
planning is the responsibility of the jurisdiction and should be considered as part
of the initial order.
o Depending on the jurisdiction’s roll-out plan, the entire allocation may not need
to be ordered the first week. Any unordered doses will remain allocated to the
jurisdictions to order in the future as needed.
o After this initial bolus, a weekly supply will be made available to help sustain the
network and support site specific needs as vaccine is administered.
https://www.cdc.gov/vaccines/covid-19/downloads/Pediatric-Planning-Guide.pdf
Communications
❑ Create a communication plan that outlines strategies, audiences,
and products that will be used to promote COVID-19 vaccination
of 5–11-year-olds.
❑ Understand existing data on parent knowledge, attitudes, and
perceptions regarding vaccination (including co-administration
with influenza and routine childhood vaccines) in terms of
demand, provider types and locations where vaccination would
be preferred (e.g., pediatric clinics, schools, pharmacies), and
anticipated timing of when parents would be interested in
children being vaccinated relative to issuance of EUA or Biologics
License Application (BLA). Share these data with jurisdictions and
partners to help shape messages.
❑ Develop communications products for providers, pharmacies,
and public; align with federal messaging (e.g., How to Talk with
Parents about COVID-19 Vaccination) and ensure communication
materials are culturally and linguistically appropriate.
❑ Leverage partnerships (e.g., American Academy of Pediatrics
[AAP] State Chapters) to help mobilize providers and messaging
to families.
❑ Engage and educate partners and trusted messengers as soon as
possible (e.g., healthcare providers, community leaders, school
administrators, faith leaders and faith-based organizations).
https://www.cdc.gov/vaccines/covid-19/downloads/Pediatric-Planning-Guide.pdf
CDC’s Advisory Committee on Immunization Practices (ACIP) November 2nd and 3rd, 2021.
https://video.ibm.com/channel/VWBXKBR8af4